Insider · CIK 0001380187

Abdun-Nabi Daniel

Reports to the SEC for 3 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001380187

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-06	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−400 sh	—	—	0
2026-08-06	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+400 sh	—	—	400
2025-08-06	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+7,200 sh	—	—	7,200
2025-07-17	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1 sh	—	—	0
2025-07-17	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1 sh	—	—	1
2024-07-17	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+925 sh	—	—	925
2024-06-02	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+81 sh	—	—	277
2024-06-02	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−81 sh	—	—	0
2024-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−7 sh	—	—	0
2024-06-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7 sh	—	—	196
2023-08-09	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,571 sh	—	—	8,339
2023-08-09	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−3,571 sh	—	—	0
2023-06-02	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+3,571 sh	—	—	3,571
2023-06-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+297 sh	—	—	4,768
2023-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−297 sh	—	—	298
2022-08-09	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+3,571 sh	—	—	3,571
2022-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−298 sh	—	—	595
2022-06-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+298 sh	—	—	8,108
2021-06-04	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+893 sh	—	—	893
2021-06-01	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,678 sh	—	—	2,678
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−892 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,785 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,339 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+1,322 sh	—	—	1,322
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+170 sh	—	—	170
2020-07-02	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,571 sh	—	—	3,571
2020-05-29	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-06-25	APVOAptevo Therapeutics Inc.P Purchase	Director	PPurchase	+16.7K sh	$0.90	+$15K	109,351
2019-06-01	APVOAptevo Therapeutics Inc. · Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2019-05-31	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-03-04	EBSEmergent BioSolutions Inc.S Sale	Director, CEO	SSale	−14.6K sh	$58.11	−$846K	142,617
2019-02-28	EBSEmergent BioSolutions Inc.F Tax Payment	Director, CEO	FTax Payment	−5,101 sh	$58.71	−$299K	157,182
2019-02-27	EBSEmergent BioSolutions Inc.F Tax Payment	Director, CEO	FTax Payment	−2,570 sh	$57.98	−$149K	162,283
2019-02-26	EBSEmergent BioSolutions Inc.F Tax Payment	Director, CEO	FTax Payment	−1,714 sh	$61.01	−$105K	164,853
2018-09-17	EBSEmergent BioSolutions Inc.S Sale	Director, CEO	SSale	−1,319 sh	$65.00	−$85.7K	166,567
2018-09-17	EBSEmergent BioSolutions Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	+1,319 sh	—	—	0
2018-09-17	EBSEmergent BioSolutions Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+1,319 sh	$13.38	+$17.6K	167,886
2018-09-14	EBSEmergent BioSolutions Inc.S Sale	Director, CEO	SSale	−28.2K sh	$65.00	−$1.83M	166,567
2018-09-14	EBSEmergent BioSolutions Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	+28.2K sh	—	—	1,319
2018-09-14	EBSEmergent BioSolutions Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+28.2K sh	$13.38	+$378K	194,787
2018-09-05	EBSEmergent BioSolutions Inc.S Sale	Director, CEO	SSale	−30.8K sh	$59.49	−$1.83M	166,567
2018-09-04	EBSEmergent BioSolutions Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+60K sh	$13.38	+$803K	257,343
2018-09-04	EBSEmergent BioSolutions Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−60K sh	—	—	29,539
2018-09-04	EBSEmergent BioSolutions Inc.S Sale	Director, CEO	SSale	−60K sh	$60.54	−$3.63M	197,343
2018-06-05	EBSEmergent BioSolutions Inc.S Sale	Director, CEO	SSale	−15.8K sh	$52.11	−$823K	197,343
2018-06-01	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-05-25	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2018-03-09	EBSEmergent BioSolutions Inc.F Tax Payment	Director, CEO	FTax Payment	−7,825 sh	$51.84	−$406K	213,128
2018-02-28	EBSEmergent BioSolutions Inc.F Tax Payment	Director, CEO	FTax Payment	−6,599 sh	$49.97	−$330K	220,953

Recent filings

Accepted (ET)
Aug 104
Abdun-Nabi Daniel0001193125-26-343069
SEC(opens sec.gov)
Aug 84
Abdun-Nabi Daniel0000950170-25-105942
SEC(opens sec.gov)
Jul 214
Abdun-Nabi Daniel0000950170-25-097279
SEC(opens sec.gov)
Jul 194
Abdun-Nabi Daniel0000950170-24-084944
SEC(opens sec.gov)
Jun 34
Abdun-Nabi Daniel0000950170-24-068070
SEC(opens sec.gov)
Aug 104
Abdun-Nabi Daniel0001209191-23-045294
SEC(opens sec.gov)
Jun 24
Abdun-Nabi Daniel0001209191-23-033830
SEC(opens sec.gov)
Aug 104
Abdun-Nabi Daniel0001209191-22-045184
SEC(opens sec.gov)
Jun 34
Abdun-Nabi Daniel0001209191-22-033936
SEC(opens sec.gov)
Jun 84
Abdun-Nabi Daniel0001562180-21-004122
SEC(opens sec.gov)
Jun 24
Abdun-Nabi Daniel0001019056-21-000353
SEC(opens sec.gov)

Companies

Address

2401 4TH AVENUE SUITE 1050

SEATTLE, WA, 98121